William Blair restated their outperform rating on shares of Enovix (NASDAQ:ENVX – Free Report) in a research note released on Thursday, RTT News reports.
Other research analysts have also issued research reports about the company. Cantor Fitzgerald reiterated an overweight rating and issued a $30.00 target price on shares of Enovix in a research report on Thursday, April 25th. JPMorgan Chase & Co. dropped their target price on shares of Enovix from $18.00 to $12.00 and set an overweight rating on the stock in a report on Friday, April 26th. Canaccord Genuity Group reaffirmed a buy rating and issued a $17.00 price target on shares of Enovix in a report on Wednesday, February 21st. Finally, B. Riley dropped their price objective on shares of Enovix from $18.00 to $16.00 and set a buy rating on the stock in a research note on Tuesday, April 30th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Enovix presently has an average rating of Moderate Buy and a consensus target price of $18.33.
View Our Latest Research Report on Enovix
Enovix Price Performance
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.01). The company had revenue of $7.38 million during the quarter, compared to analyst estimates of $3.37 million. Enovix had a negative net margin of 1,448.90% and a negative return on equity of 83.66%. As a group, research analysts expect that Enovix will post -1.13 earnings per share for the current year.
Insider Transactions at Enovix
In other Enovix news, COO Ajay Marathe sold 4,954 shares of the business’s stock in a transaction dated Sunday, April 14th. The shares were sold at an average price of $7.31, for a total value of $36,213.74. Following the sale, the chief operating officer now directly owns 978,913 shares in the company, valued at $7,155,854.03. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 17.30% of the company’s stock.
Institutional Investors Weigh In On Enovix
Large investors have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC purchased a new stake in shares of Enovix during the third quarter valued at $31,000. Beacon Capital Management LLC increased its position in shares of Enovix by 66.7% in the fourth quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock worth $31,000 after acquiring an additional 1,000 shares in the last quarter. Carmel Capital Partners LLC acquired a new stake in shares of Enovix during the third quarter valued at approximately $34,000. Able Wealth Management LLC purchased a new stake in shares of Enovix in the 4th quarter valued at approximately $34,000. Finally, Quest Partners LLC acquired a new position in Enovix in the 4th quarter worth approximately $49,000. 50.92% of the stock is owned by institutional investors.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Further Reading
- Five stocks we like better than Enovix
- Health Care Stocks Explained: Why You Might Want to Invest
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- How is Compound Interest Calculated?
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- 3 Stocks to Consider Buying in October
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.